The combination of prednisolone acetate and sulfacetamide sodium is an ophthalmic (for the eye) medication used to treat inflammatory eye conditions where there is also a risk of or an existing superficial bacterial infection. It is available by prescription only as eye drops (suspension/solution) and ointment. It is grouped under the following drug class(es): Steroids. Its therapeutic use is listed as antirheumatic agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Blephamide and Sulphrin. Its PubChem CID is 90479725.
Prednisolone acetate sulfacetamide sodium
| CAS No | 288392-51-8 |
|---|---|
| Molecular Formula | C31H39N2NaO9S |
| Molecular Weight | 638.7 g/mol |
| Synonyms | sodium;acetyl-(4-aminophenyl)sulfonylazanide;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
The combination of prednisolone acetate and sulfacetamide sodium is an ophthalmic (for the eye) medication used to treat inflammatory eye conditions where there is also a risk of or an existing superficial bacterial infection.
The listed CAS number is 288392-51-8.
The listed molecular formula is C31H39N2NaO9S.
The listed molecular weight is 638.7 g/mol.
sodium;acetyl-(4-aminophenyl)sulfonylazanide;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate.
The source lists Blephamide and Sulphrin.